Efficacy and Tolerability of Pregabalin Using a Flexible, Optimized Dose Schedule in Korean Patients With Peripheral Neuropathic Pain: A 10-Week, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study (Q38476770)

From Wikidata

Jump to navigation Jump to search

scientific article published on December 1, 2010

Language	Label	Description	Also known as
English	Efficacy and Tolerability of Pregabalin Using a Flexible, Optimized Dose Schedule in Korean Patients With Peripheral Neuropathic Pain: A 10-Week, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study	scientific article published on December 1, 2010

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Efficacy and tolerability of pregabalin using a flexible, optimized dose schedule in Korean patients with peripheral neuropathic pain: a 10-week, randomized, double-blind, placebo-controlled, multicenter study (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Efficacy and Tolerability of Pregabalin Using a Flexible, Optimized Dose Schedule in Korean Patients With Peripheral Neuropathic Pain: A 10-Week, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study (English)

1 reference

10.1016/J.CLINTHERA.2011.01.014

https://api.crossref.org/works/10.1016/J.CLINTHERA.2011.01.014

25 November 2024

0 references

multicenter clinical trial

0 references

neuropathic pain

0 references

author name string

Dong Eon Moon

1

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Doo Ik Lee

2

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Sang Chul Lee

3

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Sun Ok Song

4

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Duck Mi Yoon

5

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Myung Ha Yoon

6

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Hae Kyu Kim

7

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Youn Woo Lee

8

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Chan Kim

9

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Pyung Bok Lee

10

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21353106

25 November 2024

publication date

1 December 2010

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

December 2010

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21353106

25 November 2024

full work available at URL

https://api.elsevier.com/content/article/PII:S0149291811000154?httpAccept=text/xml

1 reference

10.1016/J.CLINTHERA.2011.01.014

https://api.crossref.org/works/10.1016/J.CLINTHERA.2011.01.014

25 November 2024

https://api.elsevier.com/content/article/PII:S0149291811000154?httpAccept=text/plain

1 reference

10.1016/J.CLINTHERA.2011.01.014

https://api.crossref.org/works/10.1016/J.CLINTHERA.2011.01.014

25 November 2024

Clinical Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

32

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

14

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

2370-2385

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Neuropathic pain: emerging treatments

2

1 reference

10.1016/J.CLINTHERA.2011.01.014

https://api.crossref.org/works/10.1016/J.CLINTHERA.2011.01.014

25 November 2024

Opioids in chronic non-cancer pain: systematic review of efficacy and safety

3

1 reference

10.1016/J.CLINTHERA.2011.01.014

https://api.crossref.org/works/10.1016/J.CLINTHERA.2011.01.014

25 November 2024

Recommendations for the pharmacological management of neuropathic pain: an overview and literature update

4

1 reference

10.1016/J.CLINTHERA.2011.01.014

https://api.crossref.org/works/10.1016/J.CLINTHERA.2011.01.014

25 November 2024

Pregabalin for pain management

5

1 reference

10.1016/J.CLINTHERA.2011.01.014

https://api.crossref.org/works/10.1016/J.CLINTHERA.2011.01.014

25 November 2024

Inhibition of neuronal Ca(2+) influx by gabapentin and pregabalin in the human neocortex

6

1 reference

10.1016/J.CLINTHERA.2011.01.014

https://api.crossref.org/works/10.1016/J.CLINTHERA.2011.01.014

25 November 2024

Ca2+ channel alpha2delta ligands: novel modulators of neurotransmission

7

1 reference

10.1016/J.CLINTHERA.2011.01.014

https://api.crossref.org/works/10.1016/J.CLINTHERA.2011.01.014

25 November 2024

Gabapentin for chronic neuropathic pain in adults

8

1 reference

10.1016/J.CLINTHERA.2011.01.014

https://api.crossref.org/works/10.1016/J.CLINTHERA.2011.01.014

25 November 2024

Efficacy of pregabalin in depressive symptoms associated with generalized anxiety disorder: a pooled analysis of 6 studies

10

1 reference

10.1016/J.CLINTHERA.2011.01.014

https://api.crossref.org/works/10.1016/J.CLINTHERA.2011.01.014

25 November 2024

Efficacy and safety of pregabalin 600 mg/d for treating painful diabetic peripheral neuropathy: a double-blind placebo-controlled trial

11

1 reference

10.1016/J.CLINTHERA.2011.01.014

https://api.crossref.org/works/10.1016/J.CLINTHERA.2011.01.014

25 November 2024

Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trial

12

1 reference

10.1016/J.CLINTHERA.2011.01.014

https://api.crossref.org/works/10.1016/J.CLINTHERA.2011.01.014

25 November 2024

Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens

13

1 reference

10.1016/J.CLINTHERA.2011.01.014

https://api.crossref.org/works/10.1016/J.CLINTHERA.2011.01.014

25 November 2024

Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trial

14

1 reference

10.1016/J.CLINTHERA.2011.01.014

https://api.crossref.org/works/10.1016/J.CLINTHERA.2011.01.014

25 November 2024

Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial

15

1 reference

10.1016/J.CLINTHERA.2011.01.014

https://api.crossref.org/works/10.1016/J.CLINTHERA.2011.01.014

25 November 2024

Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial

16

1 reference

10.1016/J.CLINTHERA.2011.01.014

https://api.crossref.org/works/10.1016/J.CLINTHERA.2011.01.014

25 November 2024

Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: results of a randomised, placebo-controlled clinical trial.

17

1 reference

10.1016/J.CLINTHERA.2011.01.014

https://api.crossref.org/works/10.1016/J.CLINTHERA.2011.01.014

25 November 2024

Pregabalin for postherpetic neuralgia: placebo-controlled trial of fixed and flexible dosing regimens on allodynia and time to onset of pain relief

18

1 reference

10.1016/J.CLINTHERA.2011.01.014

https://api.crossref.org/works/10.1016/J.CLINTHERA.2011.01.014

25 November 2024

Pregabalin for relief of neuropathic pain associated with diabetic neuropathy: a randomized, double-blind study

19

1 reference

10.1016/J.CLINTHERA.2011.01.014

https://api.crossref.org/works/10.1016/J.CLINTHERA.2011.01.014

25 November 2024

Efficacy and tolerability of twice-daily pregabalin for treating pain and related sleep interference in postherpetic neuralgia: a 13-week, randomized trial

20

1 reference

10.1016/J.CLINTHERA.2011.01.014

https://api.crossref.org/works/10.1016/J.CLINTHERA.2011.01.014

25 November 2024

Reliability, validity, and responsiveness of the daily sleep interference scale among diabetic peripheral neuropathy and postherpetic neuralgia patients

21

1 reference

10.1016/J.CLINTHERA.2011.01.014

https://api.crossref.org/works/10.1016/J.CLINTHERA.2011.01.014

25 November 2024

Modeling Valuations for EuroQol Health States

22

1 reference

10.1016/J.CLINTHERA.2011.01.014

https://api.crossref.org/works/10.1016/J.CLINTHERA.2011.01.014

25 November 2024

Psychometric properties of the Medical Outcomes Study Sleep measure

23

1 reference

10.1016/J.CLINTHERA.2011.01.014

https://api.crossref.org/works/10.1016/J.CLINTHERA.2011.01.014

25 November 2024

Psychometric properties of the MOS (Medical Outcomes Study) Sleep Scale in patients with neuropathic pain

24

1 reference

10.1016/J.CLINTHERA.2011.01.014

https://api.crossref.org/works/10.1016/J.CLINTHERA.2011.01.014

25 November 2024

The hospital anxiety and depression scale

25

1 reference

10.1016/J.CLINTHERA.2011.01.014

https://api.crossref.org/works/10.1016/J.CLINTHERA.2011.01.014

25 November 2024

Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale

26

1 reference

10.1016/J.CLINTHERA.2011.01.014

https://api.crossref.org/works/10.1016/J.CLINTHERA.2011.01.014

25 November 2024

Clinical global impressions in Alzheimer's clinical trials.

27

1 reference

10.1016/J.CLINTHERA.2011.01.014

https://api.crossref.org/works/10.1016/J.CLINTHERA.2011.01.014

25 November 2024

Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations

28

1 reference

10.1016/J.CLINTHERA.2011.01.014

https://api.crossref.org/works/10.1016/J.CLINTHERA.2011.01.014

25 November 2024

Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations

29

1 reference

10.1016/J.CLINTHERA.2011.01.014

https://api.crossref.org/works/10.1016/J.CLINTHERA.2011.01.014

25 November 2024

Comorbidities in chronic neuropathic pain

30

1 reference

10.1016/J.CLINTHERA.2011.01.014

https://api.crossref.org/works/10.1016/J.CLINTHERA.2011.01.014

25 November 2024

Pregabalin in the treatment of post-traumatic peripheral neuropathic pain: a randomized double-blind trial

31

1 reference

10.1016/J.CLINTHERA.2011.01.014

https://api.crossref.org/works/10.1016/J.CLINTHERA.2011.01.014

25 November 2024

Patient-reported outcomes in subjects with neuropathic pain receiving pregabalin: evidence from medical practice in primary care settings

32

1 reference

10.1016/J.CLINTHERA.2011.01.014

https://api.crossref.org/works/10.1016/J.CLINTHERA.2011.01.014

25 November 2024

Pharmacokinetics of pregabalin in subjects with various degrees of renal function

34

1 reference

10.1016/J.CLINTHERA.2011.01.014

https://api.crossref.org/works/10.1016/J.CLINTHERA.2011.01.014

25 November 2024

Identifiers

10.1016/J.CLINTHERA.2011.01.014

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38476770&oldid=2279561085"